New stroke drug aims to boost recovery after Clot-Busters
NCT ID NCT07581210
First seen May 19, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This study tests a new medicine called QD202 in people who have had a stroke caused by a blood clot and are receiving standard clot-busting treatment. The goal is to see if QD202 is safe and helps improve recovery. About 120 adults will receive either QD202 or a placebo as an IV infusion for 5 days, and their progress will be tracked for 90 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Benxi Central Hospital
RECRUITINGBenxi, Liaoning, China
Contact Email: •••••@•••••
Contact
-
Central Hospital Affiliated to Shenyang Medical College
RECRUITINGShengyang, Liaoning, China
Contact Email: •••••@•••••
Contact
-
General Hospital of Fuxin Mining Industry Group of Liaoning Health Industry Group
RECRUITINGFuxin, Liaoning, China
Contact Email: •••••@•••••
Contact
-
General Hospital of Northern Theater Command
RECRUITINGShenyang, Liaoning, China
Contact Email: •••••@•••••
Contact
-
Huashan Hospital Fudan University
RECRUITINGShanghai, Shanghai Municipality, China
Contact
Contact
Contact Email: •••••@•••••
Contact
-
Jilin Province People's Hospital
RECRUITINGChangchun, Jilin, China
Contact Email: •••••@•••••
Contact
-
Linfen Central Hospital
RECRUITINGLinfen, Shanxi, China
Contact Email: •••••@•••••
Contact
-
Linyi People's Hospital
RECRUITINGLinyi, Shandong, China
Contact Email: •••••@•••••
Contact
-
Luoyang Central Hospital
RECRUITINGLuoyang, Henan, China
Contact Email: •••••@•••••
Contact
-
Meihe Hospital the First Hospital of Jilin University
RECRUITINGMeihekou, Jilin, China
Contact Email: •••••@•••••
Contact
-
Meizhou People's Hospital
RECRUITINGMeizhou, Guangdong, China
Contact Email: •••••@•••••
Contact
-
Nanshi Hospital of Nanyang
RECRUITINGNanyang, Henan, China
Contact Email: •••••@•••••
Contact
-
Shanghai Tenth People's Hospital
RECRUITINGShanghai, Shanghai Municipality, China
Contact Email: •••••@•••••
Contact
-
Weifang People's Hospital
RECRUITINGWeifang, Shandong, China
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.